Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akers Biosciences (NQ: AKER )

2.850 USD +0.160 (+5.95%)
Official Closing Price Updated: 7:41 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Akers Biosciences

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages HMSY, HCAP, CBMG, and AKER Shareholders to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLIX, XLNX, SNSS, and AKER Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - AKER, INFO, SNSS, WORK, WDR
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations
From PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – IPHI, TNAV, NAV, AKER
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations
From PR Newswire
ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: 
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKER, CBMG, HLIX, and MCAC Shareholders About Its Ongoing Investigations
From PR Newswire
AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Biosciences, Inc. (NasdaqCM: AKER) with... 
From Business Wire News Releases
Looking For Hot Penny Stocks Today? 5 Making New December Highs
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Why These 4 Pharma Stocks Are Moving Today
Akers Biosciences (NASDAQ: AKER) shares are trading higher on Wednesday after the company's proposed merger partner MyMD ... 
Tags News why it's moving EARS
From Benzinga
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent
Akers Biosciences, Inc. (Nasdaq: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”) was issued US Pat. No. 10,835,523 B2, titled “Method of Regulating Tumor... 
From Business Wire News Releases
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – NAV, UROV, HDS, AKER
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers
From GlobeNewswire News Releases
Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – UROV, HDS, AKER, GV
From GlobeNewswire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of AKER, EMIS, HDS, IPHI, PNM, TGC, GV and UROV
From PR Newswire
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares moved upwards by 9.0% to $11.99 during Tuesday's after-market session. ... 
Tags Market News BKD ASRT
From Benzinga
WeissLaw LLP Reminds ALSK, EIGI, AKER, and TNAV Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Akers Biosciences,... 
From PR Newswire
REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc. ("MyMD") and Akers Biosciences, Inc. ("Akers") (NASDAQ: AKER) jointly announced a definitive merger agreement last week. The companies plan to hold a video conference for... 
From Business Wire News Releases
Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – HDS, UROV, AKER, NAV
From GlobeNewswire News Releases
AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Biosciences, Inc. (NasdaqCM: AKER) with... 
From Business Wire News Releases
RM LAW Announces Investigation of Akers Biosciences, Inc.
RM LAW, P.C. is investigating potential claims against the board of directors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) regarding possible breaches of fiduciary duties and... 
From PR Newswire
Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm
Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to... 
From PR Newswire
65 Biggest Movers From Friday
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares jumped 93.5% to close at $16.02 on Friday after the company late Thursday ... 
Tags LRMR Movers SFT
From Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant ... 
Tags EH Small Cap PECK
From Benzinga
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger
From GlobeNewswire News Releases
46 Stocks Moving in Friday's Pre-Market Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) rose 87% to $15.48 in pre-market trading. Sumitovant Biopharma will acquire Urovant ... 
Tags CBAT EDRY Benzinga
From Benzinga
SHAREHOLDER ALERT: WeissLaw LLP Investigates Akers Biosciences, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) in... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.